Article Versions Notes

Mostazo MGC, Kurrle N, Casado M, Fuhrmann D, Alshamleh I, Häupl B, Martín-Sanz P, Brüne B, Serve H, Schwalbe H, et al. Metabolic Plasticity Is an Essential Requirement of Acquired Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia. Cancers. 2020; 12(11):3443. https://doi.org/10.3390/cancers12113443

Mostazo, Miriam G. Contreras, Nina Kurrle, Marta Casado, Dominik Fuhrmann, Islam Alshamleh, Björn Häupl, Paloma Martín-Sanz, Bernhard Brüne, Hubert Serve, Harald Schwalbe, and et al. 2020. "Metabolic Plasticity Is an Essential Requirement of Acquired Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia" Cancers 12, no. 11: 3443. https://doi.org/10.3390/cancers12113443

Mostazo, M. G. C., Kurrle, N., Casado, M., Fuhrmann, D., Alshamleh, I., Häupl, B., Martín-Sanz, P., Brüne, B., Serve, H., Schwalbe, H., Schnütgen, F., Marin, S., & Cascante, M. (2020). Metabolic Plasticity Is an Essential Requirement of Acquired Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia. Cancers, 12(11), 3443. https://doi.org/10.3390/cancers12113443